the challenges in disease-modifying therapy development in parkinson’s disease
Published 11 months ago • 112 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
3:56
ikt-148009 as a potential disease-modifying therapy in parkinson's disease
-
4:47
update on disease-modifying therapies in parkinson’s disease
-
2:12
key clinical trials of disease modifying therapies in parkinson's disease
-
9:31
challenges faced in early parkinson’s disease management and the resurgence of levodopa
-
1:36
parkinson's disease: updates in the disease-modifying space
-
21:05
therapeutic development 4: the challenges of developing combination therapies (rallying 2023)
-
4:55
parkinson's disease modification through c-abl inhibition
-
46:44
disease modification in parkinson’s disease
-
2:15
disease-modifying therapies in pd – are we on the wrong track?
-
3:20
parkinson's disease: what’s to come in 2022?
-
1:01:02
the potential for disease-modifying therapies in parkinson’s disease
-
2:43
update on parkinson’s disease clinical trials
-
24:10
therapeutic development 1: disease modifying trials an overview. (rallying 2023)
-
3:30
advancements in cell therapies for parkinson’s disease
-
6:11
moving from symptomatic therapy towards disease modification in pd
-
1:44
exploratory delayed-start analysis of pasadena in early-stage parkinson's disease
-
1:25
challenges hampering clinical utility of fluid biomarkers in parkinson’s disease
-
14:59
should device-aided treatment be given earlier in parkinson’s disease?
-
8:46
new research: disease modifying treatment of parkinson's disease